ResearcherNebraska Medical CenterNo recent work listed
Wen Shi
Matched on ORCID iD 0000-0003-1138-3409; OpenAlex author ID A5001166654. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper
Papers 3
- Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer. First author DOI 10.1016/j.biomaterials.2016.05.036↗
- The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imaging. Co-author DOI 10.1016/j.biomaterials.2014.03.056↗
- 177Lu-labeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: synthesis, characterization and preliminary in vivo investigation in a pancreatic … First author DOI 10.1016/j.nucmedbio.2013.01.011↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jered C Garrison · 3 shared papers, 2013–2016 · strength 0.16
- Paper Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer. DOI 10.1016/j.biomaterials.2016.05.036↗
- Paper The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreati… DOI 10.1016/j.biomaterials.2014.03.056↗
- Paper 177Lu-labeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: synthesis, characterization and preliminar… DOI 10.1016/j.nucmedbio.2013.01.011↗
- Sunny M. Ogbomo · 2 shared papers, 2013–2014 · strength 0.09
- Paper The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreati… DOI 10.1016/j.biomaterials.2014.03.056↗
- Paper 177Lu-labeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: synthesis, characterization and preliminar… DOI 10.1016/j.nucmedbio.2013.01.011↗
- Wei Qiang Fan · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.